Skip to main content

Yoga Intervention Can Reduce Felt Stigma in Epilepsy Patients

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 9, 2023.

By Elana Gotkine HealthDay Reporter

THURSDAY, Nov. 9, 2023 -- For patients with epilepsy, yoga therapy plus psychoeducation can reduce felt stigma, according to a study published online Nov. 8 in Neurology.

Kirandeep Kaur, Ph.D., from the All India Institute of Medical Sciences in New Delhi, and colleagues conducted a randomized controlled trial to examine whether yoga and psychoeducation are effective for reducing felt stigma (primary outcome), neuropsychiatric outcomes, and seizure frequency. A total of 160 patients aged 18 to 60 years scoring higher than the cutoff score for felt stigma as measured by the Kilifi Stigma Scale were randomly assigned to receive yoga therapy plus psychoeducation or sham yoga therapy plus psychoeducation for three months.

The researchers found that the intervention arm reported a significant reduction in felt stigma compared with the control arm at the end of the follow-up period (six months). The odds of >50 percent seizure reduction and complete seizure remission were significantly higher in the intervention group (odds ratios, 4.11 and 7.4, respectively). Relative to the control group, significant improvement was also seen in symptoms of anxiety, cognitive impairment, mindfulness, and quality of life at the end of the follow-up period in the intervention group.

"Our study showed that doing yoga can alleviate the burden of epilepsy and improve the overall quality of life by reducing this perceived stigma," coauthor Manjari Tripathi, M.D., D.M., also from the All India Institute of Medical Sciences, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Small Differences in Weight Change With First-Line Antidepressants

MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...

Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea

FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...

Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD

THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.